SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes von Korbut, Anton I, Taskaeva, Iuliia S, Bgatova, Nataliya P, Muraleva, Natalia A, Orlov, Nikolai B, Dashkin, Maksim V, Khotskina, Anna S, Zavyalov, Evgenii L, Konenkov, Vladimir I, Klein, Thomas, Klimontov, Vadim V

Volltext

Chemotherapy-Induced Degradation of Glycosylated Components of the Brain Extracellular Matrix Promotes Glioblastoma Relapse Development in an Animal Model von Tsidulko, Alexandra Y., Shevelev, Oleg B., Khotskina, Anna S., Kolpakova, Mariia A., Suhovskih, Anastasia V., Kazanskaya, Galina M., Volkov, Alexander M., Aidagulova, Svetlana V., Zavyalov, Evgenii L., Grigorieva, Elvira V.

Volltext

Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice von Klimontov, Vadim V, Korbut, Anton I, Taskaeva, Iuliia S, Bgatova, Nataliya P, Dashkin, Maksim V, Orlov, Nikolai B, Khotskina, Anna S, Zavyalov, Evgenii L, Klein, Thomas

Volltext

Structure and magnetic properties of Ni-poly(p-xylylene) nanocomposites synthesized by vapor deposition polymerization von Ozerin, Sergei A., Vdovichenko, Artem Yu, Streltsov, Dmitry R., Davydov, Alexander B., Orekhov, Anton S., Vasiliev, Alexander L., Zubavichus, Yan V., Grigoriev, Evgenii I., Zavyalov, Sergei A., Oveshnikov, Leonid N., Aronzon, Boris A., Chvalun, Sergei N.

Volltext